 "OBIC's 'cell-to-sell' management plan links Ohio's research and commercial partners to focus academic research on market-based problems identified by business partners, which will ultimately lead to the commercialization of high-value industrial bio-products and manufacturing solutions. Combining development of unique germplasms with novel chemical-synthesis technologies, oils, carbohydrates and proteins will be utilized to develop specialty chemicals targeted for use in a range of bio-product applications," Dr. Stephen Myers, OBIC Director.
|
